Company Overview and News

 
Gold Maintains Support As Silver Catches Up

2018-04-20 seekingalpha
Gold prices remained range-bound but above the immediate-term trend line on Thursday as a mixture of news, both good and bad, kept the metal under its 3-month trading range ceiling. On a more positive note, however, silver outperformed and is finally showing signs of strengthening after months of lagging gold. In this report we’ll examine gold’s near-term rally prospects as its window of opportunity for doing so remains open for now but is fast closing.
Upvote Downvote

 
Why Silver ETFs May Outshine Gold ETFs

2018-04-20 zacks
Renewed expectations of higher inflation amid some strength in the U.S. economy and the resultant rise in interest rates may add to the gains in the beleaguered greenback in the short term. This may not be a great situation for gold investing but investors can pile up on silver in any case.
Upvote Downvote

 
Victory Formation Long/Short Portfolio Update - Buy Gold, Oil And Disney

2018-04-16 seekingalpha
Gold, oil and commodity related assets in March-April are driving gains on the long side of the ledger.
Upvote Downvote

 
Gold Just Got A New Safe-Haven Support

2018-04-16 seekingalpha
As if investors don't have enough incentives for safety purchases of the yellow metal, they just got another one over the weekend. The U.S.-led air strike on Syria in retaliation for the apparent use of chemical weapons by that country was the latest event which should stimulate additional interest in gold. In today's report we'll examine gold's improving psychological backdrop in light of the latest geopolitical uncertainties as we see that gold's immediate-term uptrend remains intact.
Upvote Downvote

 
SLV Weekly: Bears, Time To Capitulate

2018-04-05 seekingalpha
As you may know, I tend to write a SLV Weekly every week. Unfortunately, I was quite busy in March, working on different projects, most notably on the base metals complex - I was due to speak at a conference on copper in Madrid and on zinc and lead in London.
Upvote Downvote

 
Silver Speculative Short Positive Reaches Record-Breaking Levels

2018-03-25 seekingalpha
Gold speculators continued to cut back on gold positions just prior to the late-week gold rally.
Upvote Downvote

 
Gold & Silver Spell Relief

2018-03-22 seekingalpha
Gold and silver prices benefited, as did securities tracking the precious metals, as the U.S. dollar depreciated after the Fed monetary policy release and discussion.
Upvote Downvote

 
Credit Suisse Silver Shares Covered Call ETN: A Good Holding For Silver Bulls Right Now

2018-03-18 seekingalpha
Silver has been relatively range-bound in price for the past several years, presenting an ideal situation for the use of a covered call writing strategy.
Upvote Downvote

 
Silver Positioning Makes Silver An Attractive Contrarian Buy

2018-03-17 seekingalpha
Silver speculators continue to cut silver positions to record-low levels with a net short position of around 16,000 contracts.
Upvote Downvote

 
Gold's Near-Term Prospects Are Looking Up Again

2018-03-07 seekingalpha
After spending the last few weeks in a lackluster sideways trend, the gold price is finally showing signs of life again after last week's brief scare. Encouragingly, gold showed strength on Tuesday even despite a lifting of the "fear factor." As we'll discuss here, the fact that gold is rallying without a sustained fear component is even better for its intermediate-term prospects.
Upvote Downvote

 
A Second Chance For Gold In March

2018-03-05 seekingalpha
Just when it looked like gold's support was gone, back comes the safety bid as the fear factor returned last week. Renewed concerns over domestic trade policy and its possible impact on the U.S. economy put gold back into the spotlight last Friday. In today's comments I'll make the case for an upside resolution to gold's lateral trend at some point in March. We'll also examine some factors which would boost the odds of a gold turnaround this month in our latest discussion of the near-term outlook.
Upvote Downvote

 
Record-High COT Short Position Means Silver Is The Place To Be For Contrarians

2018-03-05 seekingalpha
Trade wars are inflationary and bearish for the US Dollar and thus should help precious metals.
Upvote Downvote

 
SLV / iShares Silver Trust FORM 10-K (Annual Report)

2018-02-28 sec.gov
slv20171231_10k.htm Table of Contents &n
Upvote Downvote

 
Gold: Potential New Dollar Cycle Could Upset The Apple Tart

2018-02-28 seekingalpha
The downswing in the gold price (NYSE:GLD) yesterday should definitely put swing traders on alert that lower prices are coming. Gold now is in clear danger of breaking though the lows its printed on the 9th of February last which was clearly a daily cycle low in my opinion. Why? Well the present intermediate cycle kicked offed proceedings on the 11th of December last year. Therefore the 9th of February last was 2 calendar months or roughly 30 to 40 trading days (which is typical daily cycle length) since the intermediate bottom back in December.
Upvote Downvote

 
What Gold Investors Should Expect Heading Into The Chinese New Year

2018-02-19 seekingalpha
Last week, speculative gold positions declined for the second straight week as both longs and shorts cut positions.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 46428Q109